{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:07:44Z","timestamp":1788473264311,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-1172-9-73","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T17:02:44Z","timestamp":1399568564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Brain\u2013blood amino acid correlates following protein restriction in murine maple syrup urine disease"],"prefix":"10.1186","volume":"9","author":[{"given":"Kara R","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erland","family":"Arning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi L","family":"Wasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro","family":"Bottiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"757_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymgme.2013.02.011","volume":"109","author":"KJ Skvorak","year":"2013","unstructured":"Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, Arning E, Bottiglieri T, Gibson KM, Strom SC: Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab. 2013, 109: 132-138. 10.1016\/j.ymgme.2013.02.011.","journal-title":"Mol Genet Metab"},{"key":"757_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.26150","volume":"57","author":"KJ Skvorak","year":"2013","unstructured":"Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, Gibson KM, Strom SC: Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology. 2013, 57: 1017-1023. 10.1002\/hep.26150.","journal-title":"Hepatology"},{"key":"757_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10545-012-9524-8","volume":"36","author":"KR Vogel","year":"2013","unstructured":"Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM: Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice. J Inherit Metab Dis. 2013, 36: 513-523. 10.1007\/s10545-012-9524-8.","journal-title":"J Inherit Metab Dis"},{"key":"757_CR4","volume-title":"Molec Genet Metab","author":"KR Vogel","year":"2013","unstructured":"Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM: Characterization of 2-(Methylamino)Alkanoic acids capacity to restrict blood\u2013brain Phenylalanine transport in Pahenu2 Mice: preliminary findings. Molec Genet Metab. 2013, Aug 15 [Epub ahead of print]"},{"issue":"4","key":"757_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","volume":"99","author":"KA Strauss","year":"2010","unstructured":"Strauss KA, Wardley B, Robinson D, Hendrickson C, Rider NL, Puffenberger EG, Shellmer D, Moser AB, Morton DH: Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab. 2010, 99 (4): 333-345. 10.1016\/j.ymgme.2009.12.007.","journal-title":"Mol Genet Metab"},{"key":"757_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10545-006-0223-1","volume":"29","author":"C le Roux","year":"2006","unstructured":"le Roux C, Murphy E, Hallam P, Lilburn M, Orlowska D, Lee P: Neuropsychometric outcome predictors for adults with maple syrup urine disease. J Inherit Metab Dis. 2006, 29: 201-202. 10.1007\/s10545-006-0223-1.","journal-title":"J Inherit Metab Dis"},{"key":"757_CR7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI67217","volume":"123","author":"ER Muelly","year":"2013","unstructured":"Muelly ER, Moore GJ, Bunce SC, Mack J, Bigler DC, Morton DH, Strauss KA: Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest. 2013, 123: 1809-1820. 10.1172\/JCI67217.","journal-title":"J Clin Invest"},{"issue":"1","key":"757_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpeds.2011.06.033","volume":"160","author":"GV Mazariegos","year":"2012","unstructured":"Mazariegos GV, Morton DH, Sindhi R, Soltys K, Nayyar N, Bond G, Shellmer D, Shneider B, Vockley J, Strauss KA: Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United network for organ sharing experience. J Pediatr. 2012, 160 (1): 116-121.e1. 10.1016\/j.jpeds.2011.06.033.","journal-title":"J Pediatr"},{"key":"757_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1542\/peds.109.6.999","volume":"109","author":"DH Morton","year":"2002","unstructured":"Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI: Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002, 109: 999-1008. 10.1542\/peds.109.6.999.","journal-title":"Pediatrics"},{"key":"757_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10545-007-0475-4","volume":"30","author":"E Simon","year":"2007","unstructured":"Simon E, Schwarz M, Wendel U: Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis. 2007, 30: 264-10.1007\/s10545-007-0475-4.","journal-title":"J Inherit Metab Dis"},{"key":"757_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Sch\u00f6nberger","year":"2004","unstructured":"Sch\u00f6nberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U: Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab. 2004, 82: 69-75. 10.1016\/j.ymgme.2004.01.016.","journal-title":"Mol Genet Metab"},{"key":"757_CR12","volume-title":"J Inherit Metab Dis","author":"D Klee","year":"2013","unstructured":"Klee D, Thimm E, Wittsack HJ, Schubert D, Primke R, Pentang G, Schaper J, M\u00f6dder U, Antoch A, Wendel U, Cohnen M: Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis. 2013, Jan 25. [Epub ahead of print]."},{"key":"757_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s10897-012-9490-1","volume":"21","author":"W Packman","year":"2012","unstructured":"Packman W, Mehta I, Rafie S, Mehta J, Naldi M, Mooney KH: Young adults with MSUD and their transition to adulthood: psychosocial issues. J Genet Couns. 2012, 21: 692-703. 10.1007\/s10897-012-9490-1.","journal-title":"J Genet Couns"},{"issue":"7","key":"757_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/mds.23629","volume":"26","author":"M Carecchio","year":"2011","unstructured":"Carecchio M, Schneider SA, Chan H, Lachmann R, Lee PJ, Murphy E, Bhatia KP: Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord. 2011, 26 (7): 1324-1328. 10.1002\/mds.23629.","journal-title":"Mov Disord"},{"issue":"1","key":"757_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1399-3046.2010.01411.x","volume":"15","author":"DA Shellmer","year":"2011","unstructured":"Shellmer DA, DeVito DA, Dew MA, Noll RB, Feldman H, Strauss KA, Morton DH, Vockley J, Mazariegos GV: Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series. Pediatr Transplant. 2011, 15 (1): 58-64. 10.1111\/j.1399-3046.2010.01411.x.","journal-title":"Pediatr Transplant"},{"issue":"4","key":"757_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/13854040903527279","volume":"24","author":"KS Walsh","year":"2010","unstructured":"Walsh KS, Scott MN: Neurocognitive profile in a case of maple syrup urine disease. Clin Neuropsychol. 2010, 24 (4): 689-700. 10.1080\/13854040903527279.","journal-title":"Clin Neuropsychol"},{"key":"757_CR17","volume-title":"GeneReviews\u2122 [Internet]","author":"KA Strauss","year":"2006","unstructured":"Strauss KA, Puffenberger EG, Morton DH: Maple Syrup Urine Disease. GeneReviews\u2122 [Internet]. Edited by: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K. 2006, Seattle: University of Washington, Seattle, Jan 30 [updated 2013 May 09]."},{"key":"757_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS: Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis. 2005, 20: 155-167. 10.1007\/s11011-005-4152-8.","journal-title":"Metab Brain Dis"},{"key":"757_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/glia.20072","volume":"48","author":"C Funchal","year":"2004","unstructured":"Funchal C, Gottfried C, De Almeida LM, Wajner M, Pessoa-Pureur R: Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex. Glia. 2004, 48: 230-240. 10.1002\/glia.20072.","journal-title":"Glia"},{"key":"757_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","volume":"41","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR: Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008, 41: 317-324. 10.1016\/j.clinbiochem.2007.11.015.","journal-title":"Clin Biochem"},{"key":"757_CR21","doi-asserted-by":"publisher","first-page":"E1167","DOI":"10.1152\/ajpendo.00193.2003","volume":"285","author":"RL O\u2019Kane","year":"2003","unstructured":"O\u2019Kane RL, Hawkins RA: Na\u2009+\u2009-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood\u2013brain barrier. Am J Physiol Endocrinol Metab. 2003, 285: E1167-E1173.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"757_CR22","doi-asserted-by":"crossref","first-page":"1531S","DOI":"10.1093\/jn\/135.6.1531S","volume":"135","author":"M Yudkoff","year":"2005","unstructured":"Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, Lazarow A, Nissim I: Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005, 135: 1531S-1538S.","journal-title":"J Nutr"},{"key":"757_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W","volume":"21","author":"M Yudkoff","year":"1997","unstructured":"Yudkoff M: Brain metabolism of branched-chain amino acids. Glia. 1997, 21: 92-98. 10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W.","journal-title":"Glia"},{"key":"757_CR24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1471-4159.1992.tb09409.x","volume":"59","author":"PR Dodd","year":"1992","unstructured":"Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, Johnston GA: Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem. 1992, 59: 582-590. 10.1111\/j.1471-4159.1992.tb09409.x.","journal-title":"J Neurochem"},{"issue":"Pt 4","key":"757_CR25","first-page":"903","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, Bewley MC, Cheng KC, Lanoue KF, Flanagan JM: Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009, 132 (Pt 4): 903-918.","journal-title":"Brain"},{"key":"757_CR26","volume-title":"Cell Mol Neurobiol","author":"A Sitta","year":"2013","unstructured":"Sitta A, Ribas GS, Mescka CP, Barschak AG, Wajner M, Vargas CR: Neurological damage in MSUD: the role of oxidative stress. Cell Mol Neurobiol. 2013, Nov 13. [Epub ahead of print]."},{"issue":"14","key":"757_CR27","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1016\/S0021-9258(19)84595-7","volume":"261","author":"TB Choi","year":"1986","unstructured":"Choi TB, Pardridge WM: Phenylalanine transport at the human blood\u2013brain barrier. Studies with isolated human brain capillaries. J Biol Chem. 1986, 261 (14): 6536-6541.","journal-title":"J Biol Chem"},{"key":"757_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1471-4159.1987.tb01039.x","volume":"49","author":"QR Smith","year":"1987","unstructured":"Smith QR, Momma S, Aoyagi M, Rapoport SI: Kinetics of neutral amino acid transport across the blood\u2013brain barrier. J Neurochem. 1987, 49: 1651-1658. 10.1111\/j.1471-4159.1987.tb01039.x.","journal-title":"J Neurochem"},{"issue":"1","key":"757_CR29","first-page":"61","volume":"17","author":"DM Ney","year":"2014","unstructured":"Ney DM, Blank RD, Hansen KE: Advances in the nutritional and pharmacological management of phenylketonuria. Curr Opin Clin Nutr Metab Care. 2014, 17 (1): 61-68.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"757_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/hmg\/ddq507","volume":"20","author":"N Brunetti-Pierri","year":"2011","unstructured":"Brunetti-Pierri N, Lanpher B, Erez A, Ananieva EA, Islam M, Marini JC, Sun Q, Yu C, Hegde M, Li J, Wynn RM, Chuang DT, Hutson S, Lee B: Phenylbutyrate therapy for maple syrup urine disease. Hum Mol Genet. 2011, 20 (4): 631-640. 10.1093\/hmg\/ddq507.","journal-title":"Hum Mol Genet"},{"key":"757_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/lt.22443","volume":"18","author":"I Popescu","year":"2012","unstructured":"Popescu I, Dima SO: Domino liver transplantation: how far can we push the paradigm?. Liver Transpl. 2012, 18: 22-28. 10.1002\/lt.22443.","journal-title":"Liver Transpl"},{"issue":"3","key":"757_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-6143.2005.01209.x","volume":"6","author":"KA Strauss","year":"2006","unstructured":"Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, Robinson DL, Hendrickson C, Virji M, Cropcho L, Puffenberger EG, McGhee W, Seward LM, Morton DH: Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant. 2006, 6 (3): 557-564. 10.1111\/j.1600-6143.2005.01209.x.","journal-title":"Am J Transplant"},{"key":"757_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbadis.2009.08.006","volume":"1792","author":"KJ Skvorak","year":"2009","unstructured":"Skvorak KJ, Hager EJ, Arning E, Bottiglieri T, Paul HS, Strom SC, Homanics GE, Sun Q, Jansen EE, Jakobs C, Zinnanti WJ, Gibson KM: Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta. 2009, 1792: 1004-1010. 10.1016\/j.bbadis.2009.08.006.","journal-title":"Biochim Biophys Acta"},{"key":"757_CR34","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/mt.2009.99","volume":"17","author":"KJ Skvorak","year":"2009","unstructured":"Skvorak KJ, Paul HS, Dorko K, Marongiu F, Ellis E, Chace D, Ferguson C, Gibson KM, Homanics GE, Strom SC: Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther. 2009, 17: 1266-1273. 10.1038\/mt.2009.99.","journal-title":"Mol Ther"},{"key":"757_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00726-009-0387-8","volume":"39","author":"JE Antflick","year":"2010","unstructured":"Antflick JE, Baker GB, Hampson DR: The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice. Amino Acids. 2010, 39: 145-153. 10.1007\/s00726-009-0387-8.","journal-title":"Amino Acids"},{"key":"757_CR36","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1515\/CCLM.2011.200","volume":"49","author":"SB Narayan","year":"2011","unstructured":"Narayan SB, Ditewig-Meyers G, Graham KS, Scott R, Bennett MJ: Measurement of plasma amino acids by Ultraperformance\u00ae Liquid Chromatography. Clin Chem Lab Med. 2011, 49: 1177-1185.","journal-title":"Clin Chem Lab Med"},{"key":"757_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-0404.1970.tb05606.x","volume":"46","author":"TW Barber","year":"1970","unstructured":"Barber TW, Brockway JA, Higgins LS: The density of tissues in and about the head. Acta Neurol Scand. 1970, 46: 85-92. 10.1111\/j.1600-0404.1970.tb05606.x.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"757_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","volume":"59","author":"B Hoffmann","year":"2006","unstructured":"Hoffmann B, Helbling C, Schadewaldt P, Wendel U: Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. Pediatr Res. 2006, 59 (1): 17-20. 10.1203\/01.pdr.0000190571.60385.34.","journal-title":"Pediatr Res"},{"issue":"1","key":"757_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0005-2736(75)90347-8","volume":"401","author":"WM Pardridge","year":"1975","unstructured":"Pardridge WM, Oldendorf WH: Kinetic analysis of blood\u2013brain barrier transport of amino acids. Biochim Biophys Acta. 1975, 401 (1): 128-136. 10.1016\/0005-2736(75)90347-8.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"757_CR40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jn\/109.2.304","volume":"109","author":"JK Tews","year":"1979","unstructured":"Tews JK, Kim YW, Harper AE: Induction of threonine imbalance by dispensable amino acids: relation to competition for amino acid transport into brain. J Nutr. 1979, 109 (2): 304-315.","journal-title":"J Nutr"},{"issue":"3","key":"757_CR41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jn\/110.3.394","volume":"110","author":"JK Tews","year":"1980","unstructured":"Tews JK, Kim YW, Harper AE: Induction of threonine imbalance by dispensable amino acids: relationships between tissue amino acids and diet in rats. J Nutr. 1980, 110 (3): 394-408.","journal-title":"J Nutr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-9-73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:42:26Z","timestamp":1630554146000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-9-73","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]},"assertion":[{"value":"19 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"73"}}